Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.

TitleGenetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.
Publication TypeJournal Article
Year of Publication2008
AuthorsJ Babu R, M Seibenhener L, Peng J, Strom A-L, Kemppainen R, Cox N, Zhu H, Wooten MC, Diaz-Meco MT, Moscat J, Wooten MW
JournalJ Neurochem
Volume106
Issue1
Pagination107-20
Date Published2008 Jul
ISSN1471-4159
KeywordsAdaptor Proteins, Signal Transducing, Aging, Animals, Brain, Brain-Derived Neurotrophic Factor, Disease Models, Animal, Glycogen Synthase Kinase 3, Glycogen Synthase Kinase 3 beta, Heat-Shock Proteins, Humans, JNK Mitogen-Activated Protein Kinases, Metabolic Syndrome, Mice, Mice, Knockout, Mitogen-Activated Protein Kinase 1, Molecular Chaperones, Nerve Degeneration, Neurofibrillary Tangles, Neurons, Obesity, Phosphorylation, Proto-Oncogene Proteins c-akt, Sequestosome-1 Protein, Signal Transduction, Solubility, tau Proteins
Abstract

The signaling adapter p62 plays a coordinating role in mediating phosphorylation and ubiquitin-dependent trafficking of interacting proteins. However, there is little known about the physiologic role of this protein in brain. Here, we report age-dependent constitutive activation of glycogen synthase kinase 3beta, protein kinase B, mitogen-activated protein kinase, and c-Jun-N-terminal kinase in adult p62(-/-) mice resulting in hyperphosphorylated tau, neurofibrillary tangles, and neurodegeneration. Biochemical fractionation of p62(-/-) brain led to recovery of aggregated K63-ubiquitinated tau. Loss of p62 was manifested by increased anxiety, depression, loss of working memory, and reduced serum brain-derived neurotrophic factor levels. Our findings reveal a novel role for p62 as a chaperone that regulates tau solubility thereby preventing tau aggregation. This study provides a clear demonstration of an Alzheimer-like phenotype in a mouse model in the absence of expression of human genes carrying mutations in amyloid-beta protein precursor, presenilin, or tau. Thus, these findings provide new insight into manifestation of sporadic Alzheimer disease and the impact of obesity.

DOI10.1111/j.1471-4159.2008.05340.x
Alternate JournalJ Neurochem
PubMed ID18346206
Grant ListNS-33661 / NS / NINDS NIH HHS / United States
Related Faculty: 
Jorge Moscat, Ph.D. Maria Diaz-Meco Conde, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700